Soni Manmeet Singh — SEC insider filings
SEC reporting owner CIK 1569769. 33 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2020-08-14 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 3,045,190 shares, $6,442,444 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 16 legs across 6 filings — 185,892 shares, $23,382,882 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 75,000 shares @ $164.62 ($12,346,298) in REATA PHARMACEUTICALS INC, filed 2023-08-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REATA PHARMACEUTICALS INC (RETA) | COO, CFO and President | 15 | 3 legs · 19,000 sh · $720,195 | 16 legs · 185,892 sh · $23,382,882 | 23 |
| Summit Therapeutics Inc. (SMMT) | COO and CFO, Director | 11 | 3 legs · 3,026,190 sh · $5,722,249 | — | 12 |
| PULSE BIOSCIENCES, INC. (PLSE) | Director | 7 | — | — | 8 |
Insider filings — Soni Manmeet Singh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 100,000 @ $1.37 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 25,000 @ $14.46 · Purchase (P): 25,000 @ $14.43 | EDGAR |
| 2025-10-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 53,361 @ $18.74 | EDGAR |
| 2025-08-19 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 11,200,000 (derivative) | EDGAR |
| 2024-09-13 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 44,052 @ $22.70 | EDGAR |
| 2024-08-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 2,800,000 (derivative) | EDGAR |
| 2024-08-13 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-04-04 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 1,100,000 (derivative) | EDGAR |
| 2023-10-16 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 2,976,190 @ $1.68 · Grant/award (A): 14,000,000 (derivative) | EDGAR |
| 2023-09-26 | 4 | REATA PHARMACEUTICALS INC (RETA) | Disposition to issuer (D): 62,621 · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 95,475 (derivative) · Disposition to issuer (D): 175,000 (derivative) · +2 more | EDGAR |
| 2023-08-17 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 1,755 @ $168.41 | EDGAR |
| 2023-08-01 | 4 | REATA PHARMACEUTICALS INC (RETA) | Conversion (C): 75,000 · Sale (S): 75,000 @ $164.62 · Option exercise (M): 75,000 (derivative) @ $0 · Option exercise (M): 75,000 (derivative) @ $72.70 · Conversion (C): 75,000 (derivative) | EDGAR |
| 2023-07-10 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 6,000 @ $0 | EDGAR |
| 2023-06-14 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 4,711 @ $99.62 · Option exercise (M): 25,000 @ $27.32 · Sale (S): 9,326 @ $99.75 · Sale (S): 9,157 @ $101.05 · Sale (S): 16,163 @ $101.98 · Sale (S): 3,643 @ $102.73 · +4 more | EDGAR |
| 2023-06-06 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-05-17 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 12,440 @ $84.32 · Sale (S): 8,867 @ $84.86 · Sale (S): 200 @ $85.64 · Sale (S): 625 @ $80.93 | EDGAR |
| 2023-05-09 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 622 @ $84.69 | EDGAR |
| 2023-03-06 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 3,587 @ $87.97 | EDGAR |
| 2023-03-01 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 35,000 (derivative) | EDGAR |
| 2023-01-04 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 23,513 @ $0 · Grant/award (A): 95,475 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 116,005 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 25,000 (derivative) · Grant/award (A): 82,446 (derivative) @ $1.13 | EDGAR |
| 2022-01-04 | 4 | REATA PHARMACEUTICALS INC (RETA) | Purchase (P): 16,000 @ $26.22 | EDGAR |
| 2021-05-21 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-02-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2021-01-06 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2020-08-14 | 4 | REATA PHARMACEUTICALS INC (RETA) | Purchase (P): 2,000 @ $100.22 · Purchase (P): 1,000 @ $100.19 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1569769 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs